Featured Research

from universities, journals, and other organizations

Genetic Mutation Linked To Infant Lung Disease

Date:
March 29, 2004
Source:
Johns Hopkins Medical Institutions
Summary:
Researchers at the Johns Hopkins Children's Center, the Cincinnati Children's Hospital Medical Center and the National Cancer Institute's Laboratory of Genomic Diversity have discovered a genetic defect associated with a severe and often fatal infant lung disease.

Researchers at the Johns Hopkins Children's Center, the Cincinnati Children's Hospital Medical Center and the National Cancer Institute's Laboratory of Genomic Diversity have discovered a genetic defect associated with a severe and often fatal infant lung disease.

Related Articles


Their findings, reported in this week's New England Journal of Medicine, confirm that mutations in the ABCA3 gene lead to a serious lack of surfactant, a mixture of fats and proteins that enables lung expansion and contraction and maintains the low surface tension needed to prevent lung collapse.

Study co-author Lawrence Nogee, M.D., a neonatologist at the Children's Center, speculates that since the ABCA3 gene is related to a family of transporter proteins, the defective ABCA3 protein may shuttle the phospholipids (compounds of fatty acids, phosphoric acid and a nitrogenous base) critical for surfactant function into the compartment in the cell where surfactant is stored.

"This kind of defective transport could lead to the production of abnormal surfactant, or,alternatively, a mutated ABCA3 gene could fail to transport out lipids toxic to surfactant function," he says.

Researchers zeroed in on ABCA3 as a candidate gene for unexplained surfactant deficiency in full-term infants because of other ABC genes' links with human diseases, the cellular location of ABCA3, and ABCA3's already suspected involvement in transporting lipids, says Nogee.

In the study, researchers first identified 21 infants with severe lung disease and surfactant deficiency of unknown causes, but whose family medical histories suggested a genetic basis for their problems.

Mutations in ABCA3 were found in 16 infants, 15 of whom died of their illness. Of the five patients without ABCA3 mutations, three infants recovered completely. Two later died from their lung disease.

Nogee notes that because one infant with the ABCA3 mutation survived its initial lung disease, some ABCA3 mutations may not be fatal.

"Our findings provide yet another clue as to what may trigger surfactant deficiency and neonatal lung disease, but the absence of an ABCA3 mutation in at least two infants in our study who developed fatal lung disease indicates that there are still other genes yet to be identified in this disease," Nogee says.

He adds that it is also necessary to study the occurrence of ABCA3 genetic mutations in the general population and determine their variability in order to narrow down which gene variants are harmless and which variants lead to disease.

The study's findings are the latest fruits from a long-standing research collaboration, funded by grants from the National Institutes of Health and the Johns Hopkins Eudowood Foundation. The team has investigated the causes of lung disease in hundreds of patients around the world.

"The study provides new insight into how the lung functions," says the study's senior author, Michael Dean, Ph.D., of the National Cancer Institute's (NCI) Laboratory of Genomic Diversity. "The lung surfactants that ABCA3 helps produce are essential for breathing and this work may provide insight into other pulmonary diseases."

"These advances are made possible by the availability of the gene sequence provided by the human genome project and by close interactions among doctors and scientists seeking to understand these diseases," adds study co-author Jeffrey Whitsett, M.D., of the Cincinnati Children's Hospital Medical Center. "As the causes of inherited disorders are increasingly understood, we all hope the knowledge gained from these studies will provide insights that will improve the lives of our patients and their families."

Previous studies conducted by Nogee and colleagues identified genetic mutations of both the surfactant protein C gene (SP-C), which results in a defective protein that researchers believe has a toxic effect on the lung metabolism of infants that can eventually lead to scarring of the lungs, and of the surfactant protein B gene (SP-B), which also results in severe surfactant delivery in newborns.

Sergey Shulenin of the NCI's Laboratory of Genomic Diversity was the lead author on the current study. Tarmo Annilo of the NCI's Laboratory of Genomic Diversity and Susan Wert of the Cincinnati Children's Hospital Medical Center also contributed to the study.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Genetic Mutation Linked To Infant Lung Disease." ScienceDaily. ScienceDaily, 29 March 2004. <www.sciencedaily.com/releases/2004/03/040329075941.htm>.
Johns Hopkins Medical Institutions. (2004, March 29). Genetic Mutation Linked To Infant Lung Disease. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2004/03/040329075941.htm
Johns Hopkins Medical Institutions. "Genetic Mutation Linked To Infant Lung Disease." ScienceDaily. www.sciencedaily.com/releases/2004/03/040329075941.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins